Replies to post #70678 on Muscle Pharm Corporation (MSLPQ)

[Rhenarium]

I think my figure IS way too low. Apologies, just laziness on my part - should take the time to look things up rather than relying on my increasingly suspect memory. The Q2 10Q says that BB made up 15% of revenue through June 30, so a $30M annual rate sounds about right.

Lack of growth on a $30M sales channel is obviously worse than lack of growth on a $10M sales channel.

At the same time, it makes 2014 sales growth for non-BB channels even more impressive - perhaps $100M non-BB growth off a $80M non-BB 2013 base instead of $100M non-BB growth off a $100M non-BB 2013 base.